{
  "documents": [
    {
      "id": "cluster_8_doc1",
      "content": "Dermatology consultation report from Granite Peak Health Services notes atypical presentation of hidradenitis suppurativa in a patient born in 1989. Recommended biological therapy initiation pending insurance approval. Documentation references prior unsuccessful antibiotic course at Mountain View Urgent Care.",
      "metadata": {
        "format": "medical_record"
      }
    },
    {
      "id": "cluster_8_doc2",
      "content": "Pre-authorization request HS-2023-0456 for adalimumab submitted March 10, 2023 by Dr. Ellen Voss at Granite Peak Dermatology. Justification cites failed conventional treatments and positive research outcomes from UCLA's 2022 HS clinical trial.",
      "metadata": {
        "format": "insurance_memo"
      }
    },
    {
      "id": "cluster_8_doc3",
      "content": "Approved procedure log shows laser excision of axillary lesions performed March 15, 2023 by Pine Ridge Surgical Associates under policy #DPX-3329. Notes indicate this as interim intervention while awaiting biological medication approval.",
      "metadata": {
        "format": "claim_form"
      }
    },
    {
      "id": "cluster_8_doc4",
      "content": "Regional Healthcare Review March 2023 highlights increased dermatology claim rates coinciding with new biological medication coverage policies. Article references 38% faster approval turnaround for inflammatory conditions compared to previous quarter's baseline metrics.",
      "metadata": {
        "format": "news_article"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_8",
    "cluster_risk": "LOW",
    "content_summary": "Dermatology patient journey involving hidradenitis suppurativa treatment including biological therapy pre-authorization, surgical intervention, and policy context.",
    "person": {
      "entities": [
        [
          "1989",
          "BIRTHDATE"
        ],
        [
          "hidradenitis suppurativa",
          "MEDICAL_CONDITION"
        ],
        [
          "adalimumab",
          "TREATMENT"
        ],
        [
          "March 10, 2023",
          "EVENT_DATE"
        ],
        [
          "March 15, 2023",
          "EVENT_DATE"
        ]
      ]
    },
    "questions": [
      {
        "q": "Which procedure did Granite Peak Health Services authorize for reference HS-2023-0456 on March 15, 2023?",
        "a": "Laser excision of axillary lesions by Pine Ridge Surgical Associates.",
        "sources": [
          "cluster_8_doc3"
        ],
        "type": "specific"
      },
      {
        "q": "What treatment trend was reported in the Regional Healthcare Review for March 2023?",
        "a": "Increased dermatology claim rates with faster biological medication approvals.",
        "sources": [
          "cluster_8_doc4"
        ],
        "type": "general"
      },
      {
        "q": "What interventions were pursued for adalimumab pre‑authorization in early 2023?",
        "a": "Adalimumab therapy and laser excision of axillary lesions.",
        "sources": [
          "cluster_8_doc2",
          "cluster_8_doc3"
        ],
        "type": "general"
      },
      {
        "q": "What was the approval time change for adalimumab pre‑authorization HS‑2023‑0456 in early 2023 according to insurance documents?",
        "a": "Adalimumab pre‑authorization HS‑2023‑0456 saw 38% faster approval.",
        "sources": [
          "cluster_8_doc2",
          "cluster_8_doc4"
        ],
        "type": "specific"
      }
    ]
  }
}